TFFP vs. RDHL, MEIP, UBX, APRE, NNVC, TXMD, APM, ACST, LSTA, and FBRX
Should you be buying TFF Pharmaceuticals stock or one of its competitors? The main competitors of TFF Pharmaceuticals include RedHill Biopharma (RDHL), MEI Pharma (MEIP), Unity Biotechnology (UBX), Aprea Therapeutics (APRE), NanoViricides (NNVC), TherapeuticsMD (TXMD), Aptorum Group (APM), Acasti Pharma (ACST), Lisata Therapeutics (LSTA), and Forte Biosciences (FBRX). These companies are all part of the "pharmaceutical preparations" industry.
TFF Pharmaceuticals (NASDAQ:TFFP) and RedHill Biopharma (NASDAQ:RDHL) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their community ranking, analyst recommendations, institutional ownership, media sentiment, earnings, profitability, valuation, dividends and risk.
15.3% of TFF Pharmaceuticals shares are held by institutional investors. Comparatively, 7.2% of RedHill Biopharma shares are held by institutional investors. 4.5% of TFF Pharmaceuticals shares are held by company insiders. Comparatively, 6.8% of RedHill Biopharma shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.
TFF Pharmaceuticals presently has a consensus price target of $44.00, indicating a potential upside of 2,015.38%. Given TFF Pharmaceuticals' higher possible upside, equities analysts clearly believe TFF Pharmaceuticals is more favorable than RedHill Biopharma.
TFF Pharmaceuticals has a beta of 1.44, suggesting that its share price is 44% more volatile than the S&P 500. Comparatively, RedHill Biopharma has a beta of 3.47, suggesting that its share price is 247% more volatile than the S&P 500.
RedHill Biopharma has a net margin of 0.00% compared to TFF Pharmaceuticals' net margin of -2,251.52%. RedHill Biopharma's return on equity of 0.00% beat TFF Pharmaceuticals' return on equity.
RedHill Biopharma received 360 more outperform votes than TFF Pharmaceuticals when rated by MarketBeat users. Likewise, 68.76% of users gave RedHill Biopharma an outperform vote while only 67.68% of users gave TFF Pharmaceuticals an outperform vote.
RedHill Biopharma has higher revenue and earnings than TFF Pharmaceuticals.
In the previous week, RedHill Biopharma had 1 more articles in the media than TFF Pharmaceuticals. MarketBeat recorded 4 mentions for RedHill Biopharma and 3 mentions for TFF Pharmaceuticals. TFF Pharmaceuticals' average media sentiment score of 1.25 beat RedHill Biopharma's score of 1.12 indicating that TFF Pharmaceuticals is being referred to more favorably in the media.
Summary
RedHill Biopharma beats TFF Pharmaceuticals on 10 of the 15 factors compared between the two stocks.
Get TFF Pharmaceuticals News Delivered to You Automatically
Sign up to receive the latest news and ratings for TFFP and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding TFFP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
TFF Pharmaceuticals Competitors List
Related Companies and Tools
